This phenomenon may be explained in part by the fact that these lymphocytes produce suppression of tumour growth during immune regulation [39–41], since, on the contrary, patients with high GRAMD1A expression have a higher HR of death when enriched in regulatory T cells that possess tumour-specific immunosuppressive effects [42]. Here, GRAMD1A is linked to neoplasm.